if further studies document a significantly lower frequency of ototoxicity with netilmicin , it may become the aminoglycoside of choice for patients with significant risk factors for ototoxicity , such as advanced age , renal impairment , concomitant ototoxic drug therapy and prolonged aminoglycoside administration .
C0027780
netilmicin
C0002556
aminoglycoside